Standout Papers

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in... 2019 2026 2021 2023 310
  1. Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study (2019)
    D. Ross Camidge, Rafał Dziadziuszko et al. Journal of Thoracic Oncology

Immediate Impact

6 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Single-cell multiregion dissection of Alzheimer’s disease
2024 StandoutNature
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
2024 Standout
1 intermediate paper

Works of Małgorzata Nowicka being referenced

diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering
2019

Author Peers

Author Last Decade Papers Cites
Małgorzata Nowicka 324 331 258 24 645
Scott M. Lawrence 289 198 296 32 624
Yanqing Wang 281 341 232 29 690
Sharon Glaysher 284 143 321 30 677
Ran Xie 215 178 287 31 655
M López 358 245 147 32 696
R. Molife 290 276 299 24 688
Xiaodong Su 194 274 298 35 704
Mikiko Takikita 304 128 403 19 707
David Molkentine 347 179 358 30 684
Felix Meyer 281 113 325 19 616

All Works

Loading papers...

Rankless by CCL
2026